Clinical Trial

Drug-coating Balloon Treatment in Coronary Artery Disease

Study acronym: ULTIMATE-DCB
Recruiting
View on ClinicalTrials.gov →
Summary
Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-02-02; most recent amendment 2024-11-13.
Trial Details
NCT Number NCT04255563
Lead Sponsor Nanjing First Hospital, Nanjing Medical University
Conditions Coronary Artery Disease
Enrollment 3,000 participants
Start Date 2020-02-25
Primary Completion 2030-12-30 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-15